Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2026)

Beam Therapeutics (BEAM) has 7 years of Asset Utilization Ratio data on file, last reported at 0.11 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 123.89% year-over-year to 0.11 in Q1 2026; TTM through Mar 2026 was 0.11, a 123.89% increase from a year earlier, with the FY2025 full-year figure at 0.11, up 118.18% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.11, up from 0.1 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for BEAM reached as high as 0.29 in Q3 2024 and fell as low as 0.04 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.11 across 5 years, with a median of 0.06 in 2023.
• Across the five-year window, Asset Utilization Ratio surged 176929.34% in 2022 and slumped 85.66% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.05 in 2022, then soared by 506.87% to 0.27 in 2023, then slumped by 79.67% to 0.06 in 2024, then soared by 79.27% to 0.1 in 2025, then gained by 10.64% to 0.11 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.11 in Q1 2026, 0.1 in Q4 2025, and 0.04 in Q3 2025.